News

Imagine a world where smartphones, laptops, wearables, and other electronics are powered without batteries. Researchers from MIT and elsewhere have taken a step in that direction, with the first fully flexible device that can convert energy from Wi-Fi signals into electricity that could power electronics.

In a major new study published in the journal Nature Genetics, researchers at Osaka University and their colleagues have surveyed the MHC region specifically in the Japanese population, revealing the existence of different gene variants and their connections with diseases and other traits.

Medicines for Malaria Venture (MMV) and the Drugs for Neglected Diseases initiative (DNDi) have launched the Pandemic Response Box to provide researchers with free access to 400 diverse compounds to accelerate the discovery of new treatments for life-threatening pandemic diseases.

New research on how solid particles group together in the small intestine could aid our understanding of how nutrients and drug particles are absorbed during digestion.

Cardiff University researchers have uncovered new information about the underlying mechanisms for gastric cancer, providing hope of potential new therapies in the future.

Geneticists have created a new model-in-a-dish of sporadic Alzheimer’s disease, which accounts for more than 90 percent of Alzheimer’s cases and tends to strike people without a family history of the disease.

Researchers at the Rudolf Virchow Center of the University of Würzburg have unveiled the molecular effectiveness of artemisinins. The findings could lead to drugs for diseases such as Alzheimer's, schizophrenia and epilepsy.

An engineered virus kills cancer cells more effectively than another virus currently used in treatments, according to Hokkaido University researchers.

Doctors made the world-first step by carrying out a clinical trial using stem cells from donors to create tissue that was transplanted into patients with a condition that causes blindness.

Researchers at The University of Texas MD Anderson Cancer Center have discovered an immune regulator that appears to dictate glioblastoma progression by shutting down immune surveillance, indicating a potential new area of therapeutic investigation.